Journal ArticleDOI
Global Cancer Incidence and Mortality Rates and Trends—An Update
Reads0
Chats0
TLDR
Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates.Abstract:
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.read more
Citations
More filters
Journal ArticleDOI
Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.
TL;DR: The results of the present study provide important molecular data concerning the cellular cascade, which may explain the cytotoxicity induced by ciprofloxacin in human triple-negative breast cancer cells, thus providing a novel insight into the therapeutic properties of this drug.
Journal ArticleDOI
Evaluation of colorectal cancer subtypes and cell lines using deep learning.
TL;DR: A deep learning–based method is developed to measure the similarity between CRC tumors and disease models such as cancer cell lines and efficiently leverages multiomics data sets containing copy number alterations, gene expression, and point mutations and learns latent factors that describe data in lower dimensions.
Journal ArticleDOI
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Antonio Pellino,Erika Riello,Floriana Nappo,Stefano Brignola,Sabina Murgioni,Selma Ahcene Djaballah,Sara Lonardi,Vittorina Zagonel,Massimo Rugge,Fotios Loupakis,Matteo Fassan +10 more
TL;DR: A global overview of the recent molecular classifications from The Cancer Genome Atlas and the Asian Cancer Research Group is provided and key promising developments in the field of immunotherapy and targeted therapies in metastatic GC are presented.
Journal ArticleDOI
Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species.
Wenquan Liang,Aizhen Cai,Guozhu Chen,Hongqing Xi,Xiaosong Wu,Jianxin Cui,Kecheng Zhang,Xudong Zhao,Jiyun Yu,Bo Wei,Lin Chen +10 more
TL;DR: The data show that SHK may be a novel therapeutic agent in the clinical treatment of gastric cancer and enhanced the chemotherapeutic sensitivity of 5-fluorouracil and oxaliplatin in vitro and in vivo.
Journal ArticleDOI
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.
Silvan Licher,Alis Heshmatollah,Kimberly D. van der Willik,Kimberly D. van der Willik,Bruno H. Stricker,Rikje Ruiter,Emmely W. de Roos,Lies Lahousse,Lies Lahousse,Peter J. Koudstaal,Albert Hofman,Lana Fani,Guy Brusselle,Guy Brusselle,Daniel Bos,Daniel Bos,Banafsheh Arshi,Maryam Kavousi,Maarten J.G. Leening,Maarten J.G. Leening,M. Kamran Ikram,M. Arfan Ikram +21 more
TL;DR: It is suggested that in this western European community, 9 out of 10 individuals aged 45 years and older develop an NCD during their remaining lifetime, compared to 31.8% of their remaining life for participants with all of these risk factors at baseline.
References
More filters
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
The global health burden of infection-associated cancers in the year 2002.
TL;DR: The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J Ferlay,I Soerjomataram,M Ervik,R Dikshit,S Eser,Colin Mathers,M Rebelo,D.M. Parkin,David Forman,Freddie Bray,S Elser,M Ervick,Donald Maxwell Parkin +12 more
Journal ArticleDOI
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.